FLORIDA MPJE ACTUAL LATEST EXAM 2026/2027
QUESTIONS AND SOLUTIONS RATED A+
✔✔FDA Purple Book - ✔✔Lists of Licensed Biological Products Exclusivity and
Biosimilarity or Interchangeability Evaluations
- Determines biosimilars and provides interchangeability evaluations
✔✔Medical Device Classes - ✔✔- Class 1 = lowest risk and regulation (ex. dental floss)
- Class 2 = higher risk with more regulation (ex. syringes)
- Class 3 = highest risk and regulation (ex. heart valves)
✔✔Poison Prevention Packaging Act - 1970 - ✔✔Consumer Product Safety
Commission (CPSC)
- Child-resistant containers for all prescriptions and some more high-risk OTCs (aspirin,
menthol, ibuprofen, etc)
- Physicians or patients can request an exemption
✔✔Common Exemptions from PPPA - ✔✔- OTCs specifically for the elderly
- Oral contraceptives
- Conjugated estrogens
- Norethindrone acetate
- Sublingual nitroglycerin
✔✔Federal Hazardous Substances Act - 1966 - ✔✔Overseen by Consumer Product
Safety Commission
- Requires labeling on hazardous medications
✔✔Federal Hazard Communication Standard - ✔✔Overseen by OSHA
- Staff handling hazardous material must have access to a Safety Data Sheet (SDS)
provided by the manufacturer
✔✔Centers for Medicare and Medicaid Services (CMS) Requirements - ✔✔Designs to
prevent unauthorized copying, erasure/modification, and counterfeits
✔✔Pharmacy Services at Long Term Care Facilities - ✔✔- Require a pharmacist to
conduct MTMs every 30 days
- LTCF patients can't receive more than a 14-day supply of medications (to reduce
waste)
- PRN psychotropic drug prescriptions are limited to 14 days
✔✔Mail Prescriptions - ✔✔- USPS = controls may be sent via mail delivery as long as
the packages don't have any labels or identifying information (ex. company name)
- Common Carriers (UPS, FedEx, etc) = not subject to USPS regulations on controlled
substance mailing
,✔✔Tax-Free Alcohol - ✔✔Regulated by the Alcohol and Tobacco Tax and Trade
Bureau (TTB) and ATFE
- 95% ethanol for compounding
- Permit must be acquired from TTB
- ATFE enforces
✔✔HIPAA - ✔✔- Must provide patients with a privacy notice
- PHI can only be disclosed with patient approval or for the purpose of treatment
- Business associates must enter into contracts that protect PHI
- PHI must be provided to the patient within 30 days of a request. This can be extended
for 30 additional days if the individual is notified of the reason for the delay
- The patient can amend their PHI and request a record of disclosures. Both must be
provided within 60 days (30 day extension like above)
- Patients can request records of disclosures for 6 years
- There must be a designated Privacy Official
✔✔HITECH Act - ✔✔- Must notify patients of a PHI breach within 60 days
- Breaches with fewer than 500 people require HHS to be notified annually
- Breaches affecting more than 500 people require that the Secretary of HHS and local
media be notified within 60 days of the discovery
✔✔Schdule I Drugs - ✔✔No currently accepted medical use with a high potential for
abuse
- Opiates and derivatives like heroin, LSD, etc
- Marijuana is still Schedule I in Florida
✔✔Schedule II Drugs - ✔✔High potential for abuse/addiction
- Narcotics = morphine (>0.5 mg/mL), codeine (>18 mg/mL), dihydrocodeine (>18
mg/mL), opium (>1 mg/mL), oxycodone, Vicodin, methadone, hydromorphone, fentanyl,
methadone, and cocaine (eye drops)
- Stimulants = amphetamine, methamphetamine, methylphenidate, and phenmetrazine
- Depressants = pentobarbital, glutethimide, and phencyclidine
✔✔Schedule III Drugs - ✔✔Potential for abuse, but less so than CIIs
- Narcotic Combinations = codeine (2-18 mg/mL), dihydrocodeine (1-18 mg/mL), and
morphine (0-0.5 mg/mL)
- Stimulants = chlorphentermine, phendimetrazine, and benzphetamine
- Anabolic Steroids = testosterone
- Other = ketamine and migraine combos with butalbital, ASA, and caffeine
✔✔Schedule IV Drugs - ✔✔Lower potential for abuse
- Depressants = alprazolam, diazepam, lorazepam, and phenobarbital
- Stimulants = phentermine
- Other = tramadol, carisoprodol, butorphanol, and atropine (>25 mcgs)
, ✔✔Schedule V Drugs - ✔✔Lowest potential for abuse
- Codeine (0-2 mg/mL) in antitussives
- Opium (<1mg) in antidiarrheals
- Dihydrocodeine (0-1 mg/mL)
- Pregabalin
- Seizure Meds = brivaracetam and lacosamide
✔✔Scheduling Authority for Controlled Substances - ✔✔- Federal = US Attorney
General
- State = The Florida Attorney General
✔✔Codeine Schedules - ✔✔II = >18 mg/mL
III = 2-18 mg/mL, 90 mg/dose max
V = <2 mg/mL
✔✔Dihydrocodeine Schedules - ✔✔II = >18 mg/mL
III = 1-18 mg/mL, 90 mg/dose max
V = <1 mg/mL
✔✔Opium Schedules - ✔✔II = >1 mg/mL
V = <1 mg/mL
✔✔Morphine Schedules - ✔✔II = >0.5 mg/mL
III = <0.5 mg/mL
✔✔DEA Dispenser Registration Renewal - ✔✔Every 3 years
✔✔Mid-Level Practitioner DEA Registration - ✔✔- APRNs, PAs, ambulance services,
animal shelters, and veterinary technicians
- Starts with a M
✔✔Verifying a DEA Number - ✔✔- Add the 1st, 3rd, and 5th digits
- Add 2nd, 4th, and 6th digits, then multiply by 2
- Add the two sums together
The last number of that total sum should be the last number in the DEA sequence
✔✔DEA Form 224 - ✔✔Used for dispensers including hospitals, retail pharmacies, and
teaching institutions
✔✔DEA Form 225 - ✔✔Used for manufacturers, distributors, researchers, and
importers/exporters
✔✔DEA Form 363 - ✔✔Used for narcotic treatment facilities
QUESTIONS AND SOLUTIONS RATED A+
✔✔FDA Purple Book - ✔✔Lists of Licensed Biological Products Exclusivity and
Biosimilarity or Interchangeability Evaluations
- Determines biosimilars and provides interchangeability evaluations
✔✔Medical Device Classes - ✔✔- Class 1 = lowest risk and regulation (ex. dental floss)
- Class 2 = higher risk with more regulation (ex. syringes)
- Class 3 = highest risk and regulation (ex. heart valves)
✔✔Poison Prevention Packaging Act - 1970 - ✔✔Consumer Product Safety
Commission (CPSC)
- Child-resistant containers for all prescriptions and some more high-risk OTCs (aspirin,
menthol, ibuprofen, etc)
- Physicians or patients can request an exemption
✔✔Common Exemptions from PPPA - ✔✔- OTCs specifically for the elderly
- Oral contraceptives
- Conjugated estrogens
- Norethindrone acetate
- Sublingual nitroglycerin
✔✔Federal Hazardous Substances Act - 1966 - ✔✔Overseen by Consumer Product
Safety Commission
- Requires labeling on hazardous medications
✔✔Federal Hazard Communication Standard - ✔✔Overseen by OSHA
- Staff handling hazardous material must have access to a Safety Data Sheet (SDS)
provided by the manufacturer
✔✔Centers for Medicare and Medicaid Services (CMS) Requirements - ✔✔Designs to
prevent unauthorized copying, erasure/modification, and counterfeits
✔✔Pharmacy Services at Long Term Care Facilities - ✔✔- Require a pharmacist to
conduct MTMs every 30 days
- LTCF patients can't receive more than a 14-day supply of medications (to reduce
waste)
- PRN psychotropic drug prescriptions are limited to 14 days
✔✔Mail Prescriptions - ✔✔- USPS = controls may be sent via mail delivery as long as
the packages don't have any labels or identifying information (ex. company name)
- Common Carriers (UPS, FedEx, etc) = not subject to USPS regulations on controlled
substance mailing
,✔✔Tax-Free Alcohol - ✔✔Regulated by the Alcohol and Tobacco Tax and Trade
Bureau (TTB) and ATFE
- 95% ethanol for compounding
- Permit must be acquired from TTB
- ATFE enforces
✔✔HIPAA - ✔✔- Must provide patients with a privacy notice
- PHI can only be disclosed with patient approval or for the purpose of treatment
- Business associates must enter into contracts that protect PHI
- PHI must be provided to the patient within 30 days of a request. This can be extended
for 30 additional days if the individual is notified of the reason for the delay
- The patient can amend their PHI and request a record of disclosures. Both must be
provided within 60 days (30 day extension like above)
- Patients can request records of disclosures for 6 years
- There must be a designated Privacy Official
✔✔HITECH Act - ✔✔- Must notify patients of a PHI breach within 60 days
- Breaches with fewer than 500 people require HHS to be notified annually
- Breaches affecting more than 500 people require that the Secretary of HHS and local
media be notified within 60 days of the discovery
✔✔Schdule I Drugs - ✔✔No currently accepted medical use with a high potential for
abuse
- Opiates and derivatives like heroin, LSD, etc
- Marijuana is still Schedule I in Florida
✔✔Schedule II Drugs - ✔✔High potential for abuse/addiction
- Narcotics = morphine (>0.5 mg/mL), codeine (>18 mg/mL), dihydrocodeine (>18
mg/mL), opium (>1 mg/mL), oxycodone, Vicodin, methadone, hydromorphone, fentanyl,
methadone, and cocaine (eye drops)
- Stimulants = amphetamine, methamphetamine, methylphenidate, and phenmetrazine
- Depressants = pentobarbital, glutethimide, and phencyclidine
✔✔Schedule III Drugs - ✔✔Potential for abuse, but less so than CIIs
- Narcotic Combinations = codeine (2-18 mg/mL), dihydrocodeine (1-18 mg/mL), and
morphine (0-0.5 mg/mL)
- Stimulants = chlorphentermine, phendimetrazine, and benzphetamine
- Anabolic Steroids = testosterone
- Other = ketamine and migraine combos with butalbital, ASA, and caffeine
✔✔Schedule IV Drugs - ✔✔Lower potential for abuse
- Depressants = alprazolam, diazepam, lorazepam, and phenobarbital
- Stimulants = phentermine
- Other = tramadol, carisoprodol, butorphanol, and atropine (>25 mcgs)
, ✔✔Schedule V Drugs - ✔✔Lowest potential for abuse
- Codeine (0-2 mg/mL) in antitussives
- Opium (<1mg) in antidiarrheals
- Dihydrocodeine (0-1 mg/mL)
- Pregabalin
- Seizure Meds = brivaracetam and lacosamide
✔✔Scheduling Authority for Controlled Substances - ✔✔- Federal = US Attorney
General
- State = The Florida Attorney General
✔✔Codeine Schedules - ✔✔II = >18 mg/mL
III = 2-18 mg/mL, 90 mg/dose max
V = <2 mg/mL
✔✔Dihydrocodeine Schedules - ✔✔II = >18 mg/mL
III = 1-18 mg/mL, 90 mg/dose max
V = <1 mg/mL
✔✔Opium Schedules - ✔✔II = >1 mg/mL
V = <1 mg/mL
✔✔Morphine Schedules - ✔✔II = >0.5 mg/mL
III = <0.5 mg/mL
✔✔DEA Dispenser Registration Renewal - ✔✔Every 3 years
✔✔Mid-Level Practitioner DEA Registration - ✔✔- APRNs, PAs, ambulance services,
animal shelters, and veterinary technicians
- Starts with a M
✔✔Verifying a DEA Number - ✔✔- Add the 1st, 3rd, and 5th digits
- Add 2nd, 4th, and 6th digits, then multiply by 2
- Add the two sums together
The last number of that total sum should be the last number in the DEA sequence
✔✔DEA Form 224 - ✔✔Used for dispensers including hospitals, retail pharmacies, and
teaching institutions
✔✔DEA Form 225 - ✔✔Used for manufacturers, distributors, researchers, and
importers/exporters
✔✔DEA Form 363 - ✔✔Used for narcotic treatment facilities
